Mental health
Report warns breast cancer could cost UK economy £4.2bn by 2050

The financial impact of breast cancer on the UK economy is projected to rise by nearly a third to £4.2bn within 25 years, new analysis warns.
The disease is expected to cost between £3.2bn and £3.5bn in 2025, covering NHS diagnosis and treatment as well as lost productivity when patients or carers cannot work.
A study by Breast Cancer Now and think tank Demos found that without intervention, costs could increase by 31 per cent by 2050.
The charity warned the UK faces “dire consequences” unless action ensures “everyone an equal chance of the best diagnosis, treatment and care.”
Around 56,000 new cases occur annually in the UK, with around 11,000 deaths.
Claire Rowney, chief executive of Breast Cancer Now, said the report “sets out loud and clear the huge challenges in tackling breast cancer and the dire consequences we’ll face unless urgent action is taken now to save more lives from the disease and give everyone an equal chance of the best diagnosis, treatment and care.”
She added: “Breast cancer is so far from a done deal.
“Our new report exposes the growing scale of the problem and the human and economic prices being paid – with far too many lives tragically being lost to this devastating disease.
“Great strides have been made in tackling breast cancer over past decades, but it still devastates thousands of lives in the UK each day – with people facing long anxious waits for a diagnosis or vital lifesaving treatment, or being denied the life-extending drugs they need.”
Breast cancer is one of the most common cancers in the UK, with around 56,000 new cases every year and around 11,000 deaths.
The analysis suggests raising screening uptake to 80 per cent could save up to £185m in 2025 by detecting cases earlier when treatment is more likely to succeed.
Anyone registered with a GP as female is invited for screening every three years between ages 50 and 71.
Latest figures show 70 per cent of women in England attended screening in 2023/24, up 5.4 percentage points from the previous year.
Rowney said: “We’re calling on governments and policymakers across the UK to work with Breast Cancer Now and our supporters to urgently implement measures we know will improve the lives of those impacted by breast cancer – including tackling low breast screening uptake rates and reducing health inequalities.
“Measures that will also bring about much-needed cost savings to the NHS and UK economy.”
The report said tackling health inequalities could save thousands of lives each year.
Reducing disparities in diagnosis could prevent 2,000 deaths annually in ethnic minority groups and 3,200 in the most deprived areas, while saving up to £180m and £389m respectively for the economy.
Lucy Bush, director of research and participation at Demos, which has worked with Breast Cancer Now since 2023 to model the disease’s impact, said: “In the context of the NHS 10 year plan for health announcing a shift ‘from disease cure to disease prevention’ this paper comes at a timely juncture.
“It helps draw attention to the massive opportunity we have to reduce the impact of this devastating disease on our country.
“Our work sheds a particular light on the difference that could be made by focusing on improving outcomes for ethnic minority and low-income groups.
“The disparity we see in the survival rates between different demographic groups is simply unacceptable and the uplift in wellbeing savings demonstrates what the ultimate prize would be – a reduction in the suffering and early deaths of thousands of people.”
Mental health
Women over 40 seeking raves for mental health benefits
Fertility
Housing, work and fertility stop Britons having the families they want – research
Menopause
CBT shows promise for menopause insomnia and hot flashes

Cognitive behavioural therapy (CBT) may offer short-term relief for menopause insomnia and night-time hot flushes, a pilot study suggests.
CBT is a structured, short-term talking treatment that helps people change thoughts and behaviours that can worsen sleep problems.
Researchers found the intervention was linked to meaningful short-term improvements in insomnia severity, hot flush interference, sleep self-efficacy, or confidence around sleep, and depressive symptoms.
The Menopause Society said insomnia affects an estimated 20 to 60 per cent of perimenopausal and postmenopausal women in the US.
Ongoing research is focusing on effective treatments because insomnia can have serious physical and psychological effects.
Dr Monica Christmas, associate medical director for The Menopause Society, said: “Nocturnal hot flushes (night sweats) and sleep disruption can have a significant effect on the quality of life with many women claiming extreme impairment due to symptoms that often start in early perimenopause and last 10 or more years.”
“Sleep disturbances can persist even in those using pharmacological therapy to manage hot flushes.
“The study’s findings highlight the utility of cognitive-behavioural therapy as a standalone treatment for insomnia and hot flushes, offering women an alternative or adjunct to pharmacological treatments.”
Insomnia is defined as disturbed sleep associated with distress or impaired daily functioning and is one of the most common complaints in perimenopause and postmenopause.
It can reduce quality of life and is linked to higher healthcare use and costs, disability, depression and cardiovascular disease.
Hot flushes occur in 60 to 80 per cent of women during the menopause transition and can persist for four to five years on average.
Night-time hot flushes are linked to sleep disruption, and women may respond by napping or spending longer in bed, which can help keep insomnia going.
Previous studies have shown that cognitive behavioural therapy is an effective treatment for insomnia and may also help women cope with hot flushes and other menopause symptoms.
However, few trials have looked at both insomnia and hot flushes together.
Insomnia during and after the menopause transition is complex and can have many causes, including ageing, hormone fluctuation, hot flushes, other sleep disorders, psychiatric and medical conditions and psychosocial stressors.
Because women with acute and sustained insomnia can experience greater negative health effects, effective treatment is important.
The pilot study concluded that CBT was feasible and may be a promising approach for menopause-related insomnia and nocturnal hot flushes, although the benefits appeared to lessen after three months.
Entrepreneur3 weeks agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
News2 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Fertility4 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Diagnosis3 weeks agoNew meta-analysis further supports low re-excisions and high placement accuracy with the Magseed marker
Menopause4 weeks agoMore research needed to understand link between brain fog and menopause, expert says
Mental health3 weeks agoLifting weights shows mental health and cognitive benefits in older women, study finds
News3 weeks agoResistance training has preventative effects in menopause, study finds
Pregnancy3 weeks agoNIPT or NT scan? Why the 2026 evidence supports doing Both
















